Status:
COMPLETED
A Study On An Immunostimulant Antibody In Combination With Chemotherapy For Advanced Cancer Of The Pancreas
Lead Sponsor:
Hoffmann-La Roche
Collaborating Sponsors:
University of Pennsylvania
Conditions:
Pancreatic Neoplasm
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
This study aims to seek evidence that activation of certain cells of the immune system will be safe and well tolerated in combination with cytotoxic chemotherapy. Preliminary evidence of clinical anti...
Eligibility Criteria
Inclusion
- 1st-line surgically incurable cancer of the pancreas
- ECOG(Eastern Cooperative Oncology Group) performance status 0-1
Exclusion
- Previous systemic therapy for pancreas cancer
- History of cancer-associated blood clots
- History of autoimmune disease
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2011
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT00711191
Start Date
June 1 2008
End Date
January 1 2011
Last Update
December 24 2013
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Indianapolis, Indiana, United States, 46202
2
Pfizer Investigational Site
Philadelphia, Pennsylvania, United States, 19104